Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies

Cogn Behav Neurol. 2009 Mar;22(1):63-6. doi: 10.1097/WNN.0b013e318190d195.

Abstract

Objective: To describe a case of acute nonherpetic limbic encephalitis (LE) with negative testing for antibodies directed against onconeuronal and cell membrane antigens, including voltage-gated potassium channels and N-methyl-D-aspartate receptor, that showed a dramatic response to immune therapy.

Materials and methods: A 30-year-old woman manifested generalized seizures, altered consciousness, and memory impairment shortly after a prodromal viral illness. Few days later the patient developed a drug-resistant epileptic status.

Results: Electroencephalograph showed bitemporal slowing and paroxysmal slow wave bursts. Brain magnetic resonance imaging showed bilateral swelling in the medial temporal lobes. Cerebrospinal fluid analysis ruled out viral etiologies. A diagnostic search for cancer, including serum testing for known onconeuronal antibodies proved negative. Screening for cell membrane antigen antibodies, including voltage-gated potassium channels and N-methyl-D-aspartate receptor, was also negative. Suspecting an autoimmune etiology, we started an immunomodulatory treatment with intravenous immunoglobulin followed by a short course of oral prednisone, obtaining a full clinical recovery.

Conclusions: Our report confirms previous observations of "seronegative" autoimmune LE, suggesting the presence of other, still unknown central nervous system antigens representing a target of a postinfectious, autoimmune response in these patients. Moreover, it emphasizes the importance of early recognition and treatment of acute autoimmune LE, to reduce the risk of intensive care unit-related complications and the occurrence of permanent cognitive or behavioral defects.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Anticonvulsants / therapeutic use
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / psychology
  • Autoimmune Diseases / therapy*
  • Cell Membrane / immunology
  • Electroencephalography
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Limbic Encephalitis / immunology
  • Limbic Encephalitis / psychology
  • Limbic Encephalitis / therapy*
  • Magnetic Resonance Imaging
  • Memory Disorders / etiology
  • Memory Disorders / psychology
  • Neuropsychological Tests
  • Potassium Channels, Voltage-Gated / antagonists & inhibitors*
  • Potassium Channels, Voltage-Gated / immunology*
  • Prednisone / therapeutic use
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Receptors, N-Methyl-D-Aspartate / immunology*
  • Seizures / drug therapy
  • Seizures / etiology

Substances

  • Anti-Inflammatory Agents
  • Anticonvulsants
  • Immunoglobulins, Intravenous
  • Potassium Channels, Voltage-Gated
  • Receptors, N-Methyl-D-Aspartate
  • Prednisone